BlackRock Inc. bought a new stake in shares of Atomera Incorporated (NASDAQ:ATOM - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,990,446 shares of the technology company's stock, valued at approximately $26,047,000. BlackRock Inc. owned approximately 7.72% of Atomera at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in ATOM. Defender Capital LLC. bought a new stake in shares of Atomera in the 2nd quarter valued at $2,573,000. Andar Capital Management HK Ltd bought a new position in Atomera during the second quarter worth $90,000,000. Quantum Private Wealth LLC boosted its stake in Atomera by 13.6% during the fourth quarter. Quantum Private Wealth LLC now owns 598,847 shares of the technology company's stock worth $1,323,000 after acquiring an additional 71,739 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in Atomera in the first quarter worth $621,000. Finally, Bank of New York Mellon Corp acquired a new stake in Atomera in the second quarter worth $820,000. 30.79% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Atomera news, CFO Francis Laurencio sold 20,400 shares of Atomera stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $9.44, for a total transaction of $192,576.00. Following the completion of the transaction, the chief financial officer owned 253,353 shares in the company, valued at approximately $2,391,652.32. The trade was a 7.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 8.10% of the company's stock.
Atomera Trading Up 1.5%
Shares of ATOM stock opened at $4.00 on Thursday. The firm has a fifty day simple moving average of $5.69 and a two-hundred day simple moving average of $6.35. Atomera Incorporated has a 12 month low of $1.89 and a 12 month high of $12.36. The firm has a market capitalization of $156.08 million, a PE ratio of -6.15 and a beta of 2.02.
Atomera (NASDAQ:ATOM - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The technology company reported ($0.17) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.04). The business had revenue of $0.16 million during the quarter, compared to the consensus estimate of $0.10 million. Atomera had a negative net margin of 9,742.17% and a negative return on equity of 77.91%.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. Wall Street Zen lowered shares of Atomera from a "hold" rating to a "sell" rating in a report on Monday, August 17th. Weiss Ratings raised Atomera from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of "Sell".
Read Our Latest Research Report on Atomera
Atomera Company Profile
(
Free Report)
Atomera Inc is a materials engineering company that develops and licenses advanced thin film technologies for the semiconductor industry. Its flagship offering, Mears Silicon Technology (MST), is designed to enhance transistor performance, improve power efficiency and boost device yields. Atomera's solutions are integrated into existing fabrication processes without major changes to equipment or materials flows, enabling foundries and integrated device manufacturers to adopt the technology with minimal disruption.
At the core of Atomera's business model is the licensing and patent-licensing of MST.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Atomera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Atomera wasn't on the list.
While Atomera currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.